Arbutus Biopharma Corporation
Hedge Funds Holdings
Last updated:
Arbutus Biopharma Corporation‘s stocks are currently a part of 108 hedge funds’ portfolios, which represents 35.86% of the total amount of its stocks outstanding. This makes up a total of 54.14M shares of Arbutus Biopharma Corporation. Compared to the previous quarter, the number grew by 16.36% or 7.61M shares more. As for the holding position changes, 43.52% (47) of current hedge fund investors increased the number of shares held, 26.85% (29) of current holders sold a part of the shares held, and 22.22% (24) closed the holdings completely. 11 hedge funds are new holders of Arbutus Biopharma Corporation stock in Q4 2022, it is 10.19% of total holders.
Hedge funds holding Arbutus Biopharma (Q1 2018 – Q4 2022)
| Q1 2018 | 46 |
|---|---|
| Q2 2018 | 67 |
| Q3 2018 | 85 |
| Q4 2018 | 66 |
| Q1 2019 | 67 |
| Q2 2019 | 56 |
| Q3 2019 | 44 |
| Q4 2019 | 52 |
| Q1 2020 | 43 |
| Q2 2020 | 46 |
| Q3 2020 | 61 |
| Q4 2020 | 75 |
| Q1 2021 | 89 |
| Q2 2021 | 85 |
| Q3 2021 | 97 |
| Q4 2021 | 115 |
| Q1 2022 | 109 |
| Q2 2022 | 105 |
| Q3 2022 | 120 |
| Q4 2022 | 108 |
Hedge funds changes in Arbutus Biopharma positions (Q1 2018 – Q4 2022)
| Q1 2018 | 5 | 12 | 21 | 8 | 0 |
|---|---|---|---|---|---|
| Q2 2018 | 28 | 18 | 11 | 7 | 3 |
| Q3 2018 | 27 | 25 | 20 | 9 | 4 |
| Q4 2018 | 8 | 22 | 21 | 26 | -11 |
| Q1 2019 | 6 | 23 | 18 | 6 | 14 |
| Q2 2019 | 18 | 16 | 17 | 26 | -21 |
| Q3 2019 | 6 | 10 | 21 | 18 | -11 |
| Q4 2019 | 19 | 9 | 17 | 11 | -4 |
| Q1 2020 | 11 | 16 | 10 | 18 | -12 |
| Q2 2020 | 12 | 13 | 11 | 9 | 1 |
| Q3 2020 | 30 | 9 | 16 | 15 | -9 |
| Q4 2020 | 26 | 22 | 12 | 11 | 4 |
| Q1 2021 | 25 | 22 | 20 | 9 | 13 |
| Q2 2021 | 20 | 21 | 23 | 25 | -4 |
| Q3 2021 | 25 | 31 | 22 | 13 | 6 |
| Q4 2021 | 38 | 38 | 22 | 19 | -2 |
| Q1 2022 | 14 | 39 | 34 | 20 | 2 |
| Q2 2022 | 13 | 38 | 36 | 16 | 2 |
| Q3 2022 | 21 | 40 | 32 | 6 | 21 |
| Q4 2022 | 11 | 47 | 29 | 24 | -3 |
Hedge funds changes in Arbutus Biopharma stock options (Q1 2018 – Q4 2022)
| Q1 2018 | 1,051,000 | 683,000 |
|---|---|---|
| Q2 2018 | 2,013,000 | 933,000 |
| Q3 2018 | 1,819,000 | 1,578,000 |
| Q4 2018 | 798,000 | 621,000 |
| Q1 2019 | 891,000 | 472,000 |
| Q2 2019 | 25,000 | 49,000 |
| Q3 2019 | 0 | 8,000 |
| Q4 2019 | 501,000 | 0 |
| Q1 2020 | 749,000 | 13,000 |
| Q2 2020 | 1,208,000 | 5,000 |
| Q3 2020 | 1,498,000 | 1,871,000 |
| Q4 2020 | 4,667,000 | 6,869,000 |
| Q1 2021 | 1,885,000 | 3,501,000 |
| Q2 2021 | 2,760,000 | 4,949,000 |
| Q3 2021 | 13,651,000 | 7,709,000 |
| Q4 2021 | 14,424,000 | 9,511,000 |
| Q1 2022 | 5,703,000 | 6,993,000 |
| Q2 2022 | 4,810,000 | 2,633,000 |
| Q3 2022 | 1,947,000 | 1,251,000 |
| Q4 2022 | 3,741,663 | 1,766,582 |